Collectively, these results suggest that the Glo2-D-lactate axis may contribute to metabolic rewiring associated with aggressive behavior in PTEN-deficient PCa, warranting further in vivo studies to evaluate its potential as a therapeutic target to limit tumor progression. The gene discussed is HAGH; the disease is neoplasm.